The contractor shall assist niaid in the planning and implementation of a consultation for niaid contractors and extramural programmatic staff. The consultation shall address pharmaceutical data…
Ended Awarded Last action
- Contract number
- 75N93020F00002
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $61,693
Award facts
- Contract value 100% obligated
- $61,693.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
Advanced Bioscience Laboratories, Inc. (ABL) was awarded a delivery order by the National Institute of Allergy and Infectious Diseases (NIAID) valued at $61,693 to assist with the planning and implementation of a consultation focused on pharmaceutical data integrity. The consultation will engage NIAID contractors and extramural programmatic staff as part of the agency's efforts to strengthen compliance and quality standards within its research portfolio. This delivery order was issued on July 1, 2020, with an ultimate completion date of June 30, 2021, and was performed in Potomac, Maryland under a cost-plus-fixed-fee pricing structure with no set-aside designation.
The award is issued under NIAID's Comprehensive Resources for HIV Microbicides and Biomedical Prevention Master Indefinite Delivery/Indefinite Quantity (IDIQ) vehicle, which operates as part of the broader HIV Microbicides and Biomedical Prevention program spanning 2016-2021. ABL, a contract research and manufacturing organization specializing in biologics development and manufacturing, brings substantial expertise from its previous work with NIH institutes on infectious disease countermeasures, vaccine development, and clinical support services. The consulting engagement represents a discrete effort within ABL's larger relationship with NIAID, complementing its ongoing work supporting preclinical and clinical development initiatives in HIV prevention science and related biomedical research areas.
Description
The contractor shall assist niaid in the planning and implementation of a consultation for niaid contractors and extramural programmatic staff. The consultation shall address pharmaceutical data integrity.
Quick answers
Who was awarded contract 75N93020F00002?
75N93020F00002 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 1, 2020.
How much is contract 75N93020F00002 worth?
The government has obligated $61,693 on 75N93020F00002.
Is contract 75N93020F00002 an order under another contract?
Yes. 75N93020F00002 is a delivery order under HHSN272201600008I, an indefinite delivery contract, on HIV Microbicides and Biomedical Prevention 2016-2021.
Was contract 75N93020F00002 competed?
The extent of competition for 75N93020F00002 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award